Market Analysis
Life science analytical instruments are medical devices used in hospitals, diagnostic laboratories, and pharmaceutical companies. These instruments have a wide range of applications, such as analyzing the quality of materials, analyzing the component, and composition to be used in drug development.

The growing research and development in the life science industry for the development of new innovative drugs has led to the growth of the worldwide life science and analytical instruments marketplace recently. Furthermore, the development and launch of new analytical instrument are likely to fuel the market growth. However, factors such as dearth of skilled professionals, high cost of instruments hamper the market growth. The innovation and launch of new analytical instruments used in the life science industry act as an opportunity for the market.

Market Segmentation
The life science and analytical instruments market, based on type, has been segmented into electrophoresis, spectroscopy, chromatography, flow cytometry, PCR, microscopy, next generation sequencing, centrifuges, cell counting, as well as others. The life science and analytical instruments markets, based on application, have been segmented into the research application, clinical and diagnostic applications and others. Based on end user, the market is actually segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies and others. The hospitals and diagnostic laboratories segment are likely to keep a significant share with a market value of USD 41,529.30 Million till 2025.

Regional analysis
The worldwide life science and analytical instruments market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and also the Middle East and Africa. The global life science & analytical instruments market in the Americas is segmented into North America and Latin America. In this region, North America is expected to dominate the market. The Americas is expected to command the largest market share due to rise in geriatric population, increase in the incidence of chronic diseases, including cancer and lifestyle disorders, and technological advancements in diagnostic systems.

Europe accounts for the second-largest market share in the global life science & analytical instruments market. The market growth in the European region is attributed to the presence of large number of biotechnology and pharmaceutical companies in Germany, Italy, and the UK, high and growing number of clinical trials, and the presence of a large number of research institutions and academic organizations in the region. Asia-Pacific is likely to be the fastest-growing region in the global life science & analytical instruments market owing to the presence of rapidly developing economies of China, India, and South Korea. Additionally, the Middle Eastern and Africa area is likely to show the minimum progress due to less economic developments and extremely low-income due to which the region.

Major players
Product development, mergers, innovation, and acquisition are few crucial techniques followed by the global players operating in the life science and analytical instruments market. The prominent players in the global life science & analytical instruments market are Danaher (US), Agilent Technologies, Inc (US), Perkinelmer, Inc.(US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric Company (US), Bio-Rad Laboratories, Inc.(US), Merck KGAA (Germany), Qiagen (Germany), and others.